Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis
- PMID: 18561612
Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis
Abstract
Introduction: Intensive long-term studies of Demodex spp. (D.) and its role in chronic blepharits have been carried out in recent years by scientists from the Pomeranian Medical University in Szczecin. It has resulted in numerous publications, spurring a lot of interest worldwide. A few of the papers have been cited in leading American medical journals. In recent years many papers dealing with demodicosis of the eyelids have been published worldwide. Based on the growing interest in the role of Demodex spp. in chronic blepharitis we decided to present and discuss the results of the latest experimental and clinical studies.
Material and methods: A review of the literature concerning the role of D. folliculorum and D. brevis in the pathogenesis of chronic blepharitis was done.
Results: Demodex spp. are intradermal parasites, which thrive in follicles and sebaceous glands of humans and animals. D. is spread by direct contact and probably by dust containing eggs (figs. 1, 2, 3). Currently, it is thought that pathological changes in the course of demodicosis of the eyelids are consequences of: (1) blockage of follicles and leading out tubules of sebaceous glands by the mites and by reactive hyperkeratinization and epithelial hyperplasia; (2) a mechanical vector role of bacteria; (3) host's inflammatory reaction to the presence of parasite's chitine as a foreign body; and (4) stimulation of the host's humoral responses and cell-mediated immunological reactions under the influence of the mites and their waste products. It has been established that: (1) D. folliculorum and D. brevis are cosmopolitan in terms of their distribution; (2) Infection of Demodex spp. often occurs in the course of chronic blepharitis; (3) With the increase in age, the prevalence rate of eyelid demodicosis rises; (4) Demodicosis of the eyelids may be the effect of the decrease of immunity of some patients. Treatment of demodicosis of the eyelids as a general rule lasts a few months. The use of yellow mercurial ointment, sulphur ointment, camphorated oil, crotamiton, choline esterase inhibitors, sulfacetamide, steroids, antibiotics, as well as antimycotic drugs offers some improvement. A good response has been observed after oral application of ivermectin along with topical application of cream permethrin. However, the best results were obtained after 2% metronidazole gel or ointment treatment. Medical University in Szczecin. It has resulted in numerous publications, spurring a lot of interest worldwide. A few of the papers have been cited in leading American medical journals. In recent years many papers dealing with demodicosis of the eyelids have been published worldwide. Based on the growing interest in the role ofDemodex spp. in chronic blepharitis we decided to present and discuss the results of the latest experimental and clinical studies. Material and methods: A review of the literature concerning the role of D. folliculorum and D. brevis in the pathogenesis of chronic blepharitis was done. Results: Demodex spp. are intradermal parasites, which thrive in follicles and sebaceous glands of humans and animals. D. is spread by direct contact and probably by dust containing eggs (figs. 1, 2, 3). Currently, it is thought that pathological changes in the course of demodicosis of the eyelids are consequences of: (1) blockage of follicles and leading out tubules of sebaceous glands by the mites and by reactive hyperkeratinization and epithelial hyperplasia; (2) a mechanical vector role of bacteria; (3) host's inflammatory reaction to the presence of parasite's chitine as a foreign body; and (4) stimulation of the host's humoral responses and cell-mediated immunological reactions under the influence of the mites and their waste products. It has been established that: (1) D. folliculorum and D. brevis are cosmopolitan in terms of their distribution; (2) Infection ofDemodex spp. often occurs in the course of chronic blepharitis; (3) With the increase in age, the prevalence rate of eyelid demodicosis rises; (4) Demodicosis of the eyelids may be the effect of the decrease of immunity of some patients. Treatment of demodicosis of the eyelids as a general rule lasts a few months. The use of yellow mercurial ointment, sulphur ointment, camphorated oil, crotamiton, choline esterase inhibitors, sulfacetamide, steroids, antibiotics, as well as antimycotic drugs offers some improvement. A good response has been observed after oral application of ivermectin along with topical application of cream permethrin. However, the best results were obtained after 2% metronidazole gel or ointment treatment.
Similar articles
-
[Demodex as an etiological factor in chronic blepharitis].Klin Oczna. 2005;107(10-12):722-4. Klin Oczna. 2005. PMID: 16619830 Review. Polish.
-
[Demodex folliculorum and Demodex brevis (Acarida) as the factors of chronic marginal blepharitis].Wiad Parazytol. 1991;37(1):127-30. Wiad Parazytol. 1991. PMID: 1823473 Polish.
-
[Investigations on the occurrence as well as the role of Demodex follicuforum and Demodex brevis in the pathogensis of blepharitis].Klin Oczna. 2005;107(1-3):80-2. Klin Oczna. 2005. PMID: 16052809 Polish.
-
Demodex folliculorum in hair follicles of eyelid skin.Ann Ophthalmol. 1979 Jan;11(1):37-40. Ann Ophthalmol. 1979. PMID: 420477
-
Significance of Demodex folliculorum and Demodex brevis in Pathogenesis of Dermatological Diseases-Current State of Knowledge.Medicina (Kaunas). 2025 Apr 3;61(4):660. doi: 10.3390/medicina61040660. Medicina (Kaunas). 2025. PMID: 40282951 Free PMC article. Review.
Cited by
-
Comparison of the efficacy of tea tree (Melaleuca alternifolia) oil with other current pharmacological management in human demodicosis: A Systematic Review.Parasitology. 2020 Dec;147(14):1587-1613. doi: 10.1017/S003118202000150X. Epub 2020 Aug 10. Parasitology. 2020. PMID: 32772960 Free PMC article.
-
The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1994-2005. doi: 10.1167/iovs.10-6997e. Print 2011 Mar. Invest Ophthalmol Vis Sci. 2011. PMID: 21450917 Free PMC article. Review. No abstract available.
-
Tea tree oil for Demodex blepharitis.Cochrane Database Syst Rev. 2020 Jun 20;6(6):CD013333. doi: 10.1002/14651858.CD013333.pub2. Cochrane Database Syst Rev. 2020. PMID: 32589270 Free PMC article.
-
Age differences in ocular demodicosis: Demodex profiles and clinical manifestations.Ann Transl Med. 2021 May;9(9):791. doi: 10.21037/atm-20-7715. Ann Transl Med. 2021. PMID: 34268404 Free PMC article.
-
Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series.Int Ophthalmol. 2016 Oct;36(5):691-6. doi: 10.1007/s10792-016-0188-5. Epub 2016 Feb 2. Int Ophthalmol. 2016. PMID: 26843091
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous